Epworth Hospital, Melbourne, Victoria, Australia.
Intern Med J. 2012 Oct;42 Suppl 5:44-6. doi: 10.1111/j.1445-5994.2012.02922.x.
There is no situation in medicine where outcome is so utterly dependent on time than in the treatment of patients with S-T elevation myocardial infarction. This life-threatening situation accounts for 30% of acute coronary syndromes. Prompt myocardial reperfusion saves lives, but health services need to be thoroughly organised to achieve this outcome. Unfortunately, a minority of patients in Australia present within 2 h of symptom onset and most patients receive reperfusion 3-4 h after. So health professionals begin at a disadvantage. A novel approach to this problem has been to give thrombolysis at first contact with the patient, before admission to hospital. A French study has assessed this practice against the gold standard treatment for S-T elevation myocardial infarction with some very interesting results. The implications of this study now challenge well-entrenched guidelines for the management of patients with this condition.
在医学中,没有哪种情况的结果像治疗 ST 段抬高型心肌梗死(STEMI)患者那样完全取决于时间。这种危及生命的情况占急性冠状动脉综合征的 30%。及时的心肌再灌注可以挽救生命,但需要彻底组织医疗服务以实现这一结果。不幸的是,澳大利亚只有少数患者在症状发作后 2 小时内就诊,大多数患者在发病后 3-4 小时才接受再灌注治疗。因此,医疗专业人员在开始时就处于不利地位。针对这一问题的一种新方法是在患者入院前首次接触时进行溶栓治疗。一项法国研究对这种做法进行了评估,与 STEMI 的金标准治疗相比,取得了一些非常有趣的结果。该研究的意义现在对治疗这种疾病的既定指南提出了挑战。